Navigation Links
MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
Date:11/2/2007

MT. LAUREL, N.J., Nov. 2 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) announces that its Board of Directors, in connection with its previously-disclosed review of strategic alternatives for the Company, is evaluating whether a sale of the Company is in the best interests of the Company and its shareholders, in light of the announcement earlier today by Koninklijke Philips Electronics N.V. ("Philips") of its decision to proceed with the sale of its 70% ownership interest in the Company if a satisfactory price and other acceptable terms can be realized. There is no assurance that any sale transaction will occur as a result of the evaluation.

About MedQuist:

MedQuist is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web- based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation that the Company's evaluation of whether a sale of the Company is in the best interest of the Company and its shareholders may not result in a sale of the Company, and that any potential sale transaction reviewed by the Company may not be attractive to shareholders and may not result in enhanced shareholder value. Actual outcomes and results may differ materially from what is expressed or forecasted in forward- looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Evaluating The Risks and Benefits of Hormone Therapy
2. Evaluating The Risk Factors Of Osteoporosis
3. Evaluating The Benefits Of A Low – carb Diet
4. US Doctors re-evaluating Conjoined Twin Surgery
5. VA Should Revise Its Methods for Evaluating PTSD in Ex-military Personnel
6. Experts Question Whether Expert Patient Programmes Cut Healthcare Use
7. US Court Asked to Decide Whether Childhood Vaccines can Cause Autism
8. Researchers To Test Whether ADHD Medication Helps Young Adults While Driving
9. Medicis Pharmaceutical company enters pediatric market
10. Problems Of a Growing Company
11. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: